Pouchitis Clinical Trial
Official title:
Stelara fOr ChRonic AntibioTic rEfractory pouchitiS (SOCRATES): A Belgian Open Label Multicenter Pilot-study
To evaluate the efficacy and safety of ustekinumab in the treatment of chronic antibiotic refractory and relapsing pouchitis.
This study is a Belgian prospective open label multicenter study to evaluate the efficacy and safety of ustekinumab in the treatment of relapsing or chronic antibiotic refractory pouchitis during a 48-week treatment period. Twenty subjects with a RPC and IPAA for UC who have developed relapsing or chronic antibiotic refractory pouchitis will be enrolled. All patients will receive intravenously (IV) ustekinumab ~6mg/kg at baseline and subcutaneously (SC) ustekinumab 90mg every 8 weeks thereafter until Week 48. All subjects will receive concomitant antibiotic treatment with ciprofloxacin or metronidazole from baseline through Week 4. Intravenous induction doses will be 260mg for patients <55kg, 390mg for patients between 55 and 85kg, and 520mg for patients with a body weight >85 kg. Clinical and biochemical evaluation will be planned every 8 weeks. Efficacy will be assessed at Week 16 and Week 48 using mPDAI and PDAI scores, therefor a pouchoscopy with biopsy sampling will be performed. Patients who do not achieve partial response (reduction of mPDAI score by ≥2 points from baseline) at Week 16 will be discontinued. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04979832 -
GM-CSF, Fosfomycin and Metronidazole for Pouchitis in Ulcerative Colitis Patients After Restorative IPAA Surgery
|
Phase 1/Phase 2 | |
| Terminated |
NCT00061282 -
Clotrimazole Enemas for Pouchitis in Children and Adults
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT05829109 -
Fecal Microbiota Transplant for Patients With Chronic Pouchitis
|
Early Phase 1 | |
| Recruiting |
NCT03136419 -
Microbiota and Immune microEnvironment in Pouchitis
|
N/A | |
| Withdrawn |
NCT04640155 -
Treating Chronic Pouchitis With a Low FODMAP Diet
|
N/A | |
| Completed |
NCT02201186 -
To Determine the Effect of Honey Enema in the Treatment of Patients With Acute Pouchitis
|
Phase 2 | |
| Completed |
NCT02790138 -
A Study to Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic Pouchitis
|
Phase 4 | |
| Not yet recruiting |
NCT01202396 -
The Interaction Between Intestinal Microbiota, Innate Defense and Epithelial Integrity in the Development of Pouchitis
|
N/A | |
| Completed |
NCT02428361 -
Fecal Microbiota Transplant (FMT) for Pouchitis
|
Early Phase 1 | |
| Completed |
NCT03538366 -
Fecal Microbiota Transplantation for Chronic Pouchitis
|
N/A | |
| Completed |
NCT04763564 -
Efficacy of Liraglutide Therapy in Patients With IPAA
|
Phase 2 | |
| Terminated |
NCT00583531 -
Safety and Efficacy of AST-120 in the Treatment of Antibiotic-Refractory Pouchitis
|
Phase 2 | |
| Recruiting |
NCT03524352 -
the Prophylaxis of Recurrent Pouchitis After Fecal Microbiota Transplant in UC With Ileo-anal Anastomosis
|
Phase 3 | |
| Completed |
NCT04820413 -
Faecal Microbiota Transplantation From Normal Pouch Function Donor in the Treatment of Chronic Pouchitis
|
N/A | |
| Not yet recruiting |
NCT06443502 -
A Study to Learn About the Safety of Vedolizumab and How Well it Works in Children and Teenagers With Active Chronic Pouchitis
|
Phase 3 | |
| Not yet recruiting |
NCT03526796 -
Hyperbaric Oxygen Therapy for Antibiotic Refractory Pouchitis
|
N/A | |
| Terminated |
NCT02782325 -
Safety and Efficacy of Fecal Microbiome Transplantation (FMT) in the Treatment of Antibiotic Dependent Pouchitis (ADP)
|
Phase 1/Phase 2 | |
| Completed |
NCT02828410 -
Nutritional Impact of Serum-Derived Bovine Immunoglobulin Protein Isolate in Subjects With IPAA
|
N/A | |
| Recruiting |
NCT05578313 -
Inflammatory Bowel Diseases (IBD) Cannabis Registry
|
||
| Not yet recruiting |
NCT06316999 -
Intestinal Ultrasound for the Evaluation of Pouchitis and Other Outcomes After Ileal Pouch-Anal Anastomosis
|
N/A |